EIF4EBP3 and primitive neuroectodermal tumor: Importantly, 4E-BP3 may be upregulated in several cancer types (for example, RCC or PNET) for which the mTORC1 inhibitors (the rapalogs, temsirolimus and everolimus) have been approved for treatment12, 13, 14.